State of Alaska Department of Revenue Has $12.90 Million Position in McKesson Corporation $MCK

Key Points

• State of Alaska Department of Revenue cut its McKesson stake by 28.8% in Q4 to 15,721 shares, a position valued at $12.895 million.
• McKesson beat Q4 estimates, reporting $9.34 EPS (vs. $9.19 expected) and $106.16 billion revenue (up 11.4% year-over-year), and set FY2026 guidance of $38.80–$39.20 EPS.
• The company pays a $0.82 quarterly dividend ($3.28 annual, 0.4% yield) while insiders sold about 3,592 shares (~$3.52M) last quarter; institutional investors own roughly 85% of the stock.

State of Alaska Department of Revenue lowered its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 28.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,721 shares of the company's stock after selling 6,346 shares during the quarter. State of Alaska Department of Revenue's holdings in McKesson were worth $12,895,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of MCK. GGM Financials LLC acquired a new stake in shares of McKesson during the third quarter worth about $25,000. State of Wyoming acquired a new stake in shares of McKesson during the second quarter worth about $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson during the third quarter worth about $31,000. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson during the third quarter worth about $33,000. Finally, Board of the Pension Protection Fund acquired a new stake in McKesson in the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Stock Up 0.0%

NYSE:MCK opened at $866.02 on Monday. The firm has a market capitalization of $106.08 billion, a price-to-earnings ratio of 24.91, a price-to-earnings-growth ratio of 1.25 and a beta of 0.42. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The stock's 50 day moving average price is $916.22 and its two-hundred day moving average price is $851.87.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business's quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd were given a dividend of $0.82 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson's payout ratio is 9.43%.

Insiders Place Their Bets

In other news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Maria Martinez sold 349 shares of McKesson stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the transaction, the director owned 301 shares of the company's stock, valued at $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 3,592 shares of company stock valued at $3,518,555. 0.08% of the stock is owned by insiders.

Wall Street Analyst Weigh In

MCK has been the topic of a number of recent research reports. Weiss Ratings lowered McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a research report on Thursday, February 5th. Leerink Partners reissued an "outperform" rating and issued a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Wells Fargo & Company lifted their target price on McKesson from $914.00 to $925.00 and gave the company an "equal weight" rating in a research report on Thursday, February 5th. Wall Street Zen lowered McKesson from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Morgan Stanley reissued an "overweight" rating and issued a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $970.93.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.